Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Switch Symbol:
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | -17.41% |
| Q2 2025 | 22.70% |
| Q1 2025 | -11.99% |
| Q4 2024 | 16.10% |
| Q3 2024 | -18.72% |
| Q2 2024 | 5.38% |
| Q1 2024 | -5.27% |
| Q4 2023 | -4.91% |
| Q3 2023 | 0.21% |
| Q2 2023 | 6.16% |
| Q1 2023 | -24.55% |
| Q4 2022 | 16.09% |
| Q3 2022 | 4.30% |
| Q2 2022 | 4.08% |
| Q1 2022 | -32.31% |
| Q4 2021 | 17.28% |
| Q3 2021 | 9.02% |
| Q2 2021 | 7.41% |
| Q1 2021 | -36.58% |
| Q4 2020 | 34.33% |
| Q3 2020 | 26.69% |
| Q2 2020 | -32.46% |
| Q1 2020 | -47.46% |
| Q4 2019 | 2.45% |
| Q3 2019 | 15.66% |
| Q2 2019 | 11.95% |
| Q1 2019 | -43.29% |
| Q4 2018 | 3.99% |
| Q3 2018 | 17.36% |
| Q2 2018 | 30.00% |
| Q1 2018 | 15.59% |
| Q4 2017 | -49.81% |
| Q3 2017 | 910.88% |
| Q2 2017 | -16.16% |
| Q1 2017 | -14.00% |
| Q4 2016 | -18.88% |
| Q3 2016 | -8.13% |
| Q2 2016 | 7.49% |
| Q1 2016 | -73.16% |
| Q4 2015 | 236.05% |